pokerboardgame| Keji Pharmaceuticals-B(02171): 260,000 share options granted under the initial public and after-sales share option plan, exercise price of HK$5.94
editor 2024-05-08 07:22:01 Home 34
News summary
Keji Pharmaceuticals-B (02171) granted 260,000 share options to three grantees at an exercise price of 5.5 per sharepokerboardgameHK$.94; and 60,000 RSUs were also granted to a grantee.
Newsletter text
Keji Pharmaceuticals-B(02171) granted options and restricted shares on May 7 Keji Pharmaceuticals-B(02171) has announced that it will grant grants to three option grantors under the post-IPO equity plan.pokerboardgameA total of 260,000 share options were awarded. The exercise price of these options is HK$5.94 per share, but must be accepted by the grantors before they can become effective.
At the same time, Keji Pharmaceutical also awarded 60,000 restricted share units to a restricted share unit grantor under the post-IPO restricted share unit plan. These share units also require acceptance by the grantee before they can take effect.